1,488 results on '"Rumsfeld, John S."'
Search Results
202. 2017 Roadmap for Innovation—ACC Health Policy Statement on Healthcare Transformation in the Era of Digital Health, Big Data, and Precision Health
203. Hospital Practice of Direct‐Home Discharge and 30‐Day Readmission After Transcatheter Aortic Valve Replacement in the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy (STS/ACC TVT) Registry
204. Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement
205. Procedural Experience for Transcatheter Aortic Valve Replacement and Relation to Outcomes
206. Big Data in Cardiology
207. Applicability of the IMPROVE-IT Trial to Current Patients With Acute Coronary Syndrome
208. Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End‐Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization—An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program
209. The Learning Healthcare System and Cardiovascular Care: A Scientific Statement From the American Heart Association
210. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population
211. Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention
212. Abstract 13384: Prognosis of Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries as Compared With Obstructive Coronary Disease
213. Can Big Data Fulfill Its Promise?
214. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
215. Colaboradores
216. Patient Selection for Diagnostic Coronary Angiography and Hospital-Level PCI Appropriateness: Insights from the NCDR®
217. Can We Predict Who Will Be Alive and Well After TAVR? Is That Useful to Individual Patients?
218. Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization—A Population‐Controlled Study
219. Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program
220. Variation in Hospital Risk–Adjusted Mortality Rates Following Transcatheter Aortic Valve Replacement in the United States
221. Use of Mobile Devices, Social Media, and Crowdsourcing as Digital Strategies to Improve Emergency Cardiovascular Care
222. Incorporating Health Status in Routine Care to Improve Health Care Value
223. The ACC and Google
224. Impact of the Hospital to Home Initiative on Readmissions in the VA Health Care System
225. Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention
226. Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction
227. Hospital Variation in Premature Clopidogrel Discontinuation After Drug‐Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System
228. Factors Associated With Utilization of Cardiac Rehabilitation Among Patients With Ischemic Heart Disease in the Veterans Health Administration
229. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement
230. Performance and Validation of the U.S. NCDR Acute Kidney Injury Prediction Model in Japan
231. Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program
232. Abstract 104: Group Medical Visits versus Usual Care in Heart Failure: Clinical Trial Design & Rationale
233. Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?
234. Response to Letter Regarding Article, “Facility Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention: Insights on Short-Term Healthcare Value From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System (VA CART) Program”
235. Annual Outcomes With Transcatheter Valve Therapy
236. The National Cardiovascular Data Registry Voluntary Public Reporting Program
237. Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation
238. Annual Outcomes With Transcatheter Valve Therapy
239. Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement
240. Colaboradores
241. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.
242. Achieving meaningful devices surveillance: from reaction to proaction
243. Medication Initiation Burden Required to Comply With Heart Failure Guideline Recommendations and Hospital Quality Measures
244. TCT-111 Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement: Insights from the US TVT National Registry
245. Depression and cardiovascular disease
246. TCT-618 Outcomes of TAVR in Nonagenarians in the U.S.: Insights from the STS/ACC TVT Registry
247. Facilitation of a Multihospital Community of Practice to Increase Enrollment in the Hospital to Home National Quality Improvement Initiative
248. Facility-Level Variation in Hospitalization, Mortality, and Costs in the 30 Days After Percutaneous Coronary Intervention
249. Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence Registry
250. State Mandated Public Reporting and Outcomes of Percutaneous Coronary Intervention in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.